Prof. Henry L. Y. Chan was graduated from The Chinese University of Hong Kong (CUHK) and obtained his Doctor of Medicine with commendation in 2001. He has completed the Executive Master of Business Administration degree in CUHK in 2014. He is currently Head of Division of Gastroenterology and Hepatology, Director of Institute of Digestive Disease, Director of Center for Liver Health, Director of Office of Global Engagement, and Assistant Dean (External Affairs) of Faculty of Medicine, CUHK. He is the course director of Master of Science in Gastroenterology, CUHK.

Prof. Chan is a key investigator in over 25 international trials on antiviral treatment of chronic hepatitis B and C, and is the global lead author in publications on peginterferon-alfa, peginterferon-lambda, telbivudine, and tenofovir for the treatment of viral hepatitis B. He has received numerous local, national and international research awards. His research team was awarded a Second Class National Award for Science and Technology Progress and a First-class Ministry of Health Higher Education Outstanding Scientific Research Output Award (Scientific and Technological Progress Award) in China in 2012.